An international randomised trial of candidate vaccines against COVID-19

Information on large, international, randomized controlled clinical trial is designed to enable an expeditious, agile and concurrent evaluation of the benefits and risks of multiple candidate preventive vaccines against COVID-19 at international sites with sufficient COVID-19 attack rates. The trial is powered to provide sufficient evidence of safety and vaccine efficacy against COVID-19 to support decision-making about global vaccine deployment.